Expansion of Th1-like Vγ9Vδ2T cells by new-generation IMiDs, lenalidomide and pomalidomide, in combination with zoledronic acid.
Leukemia
; 31(1): 258-262, 2017 01.
Article
in En
| MEDLINE
| ID: mdl-27698446
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
T-Lymphocytes
/
Antineoplastic Combined Chemotherapy Protocols
/
Cell Proliferation
/
Immunologic Factors
Limits:
Humans
Language:
En
Journal:
Leukemia
Year:
2017
Document type:
Article